Intermediate for Rucaparib. Rucaparib (trade name Rubraca) is a PARP inhibitor targeting the DNA repair enzyme poly-ADP ribose polymerase-1 (PARP-1) for the treatemnt of advanced ovarian cancer. Rucaparib has been approved by the U.S Food and Drug Administration on December 19, 2016.


Product Name:                  2-(2,2-Diethoxyethyl)isoindoline-1,3-dione

Synonyms:                         N/A

CAS Number:                     2913-97-5

Molecular Weight:            189.1702

Molecular Formula:          C10H7NO3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=CCN1C(=O)c2c(C1=O)cccc2


  • $69.00
  • Ex Tax: $69.00

Available Options